Cardiac fibrosis: Pathobiology and therapeutic targets
Michael P. Czubryt(St. Boniface Hospital), Taben M. Hale(Partners HealthCare Connected Health)
Cited by 72
Related Papers
MEF2C Transcription Factor Controls Chondrocyte Hypertrophy and Bone Development
|Developmental Cell|2007|457
Regulation of peroxisome proliferator-activated receptor γ coactivator 1α (PGC-1α) and mitochondrial function by MEF2 and HDAC5
|Proceedings of the National Academy of Sciences|2003|419
Requirement for serum response factor for skeletal muscle growth and maturation revealed by tissue-specific gene deletion in mice
|Proceedings of the National Academy of Sciences|2005|296
Cardiac Fibroblast Activation Post-Myocardial Infarction: Current Knowledge Gaps
|Trends in Pharmacological Sciences|2017|204
Targeting the renin-angiotensin-aldosterone system in fibrosis
|Matrix Biology|2020|187